KFC to test revamped sandwich after last year’s fried chicken frenzy

spike

NEW YORK (Reuters) – Kentucky Fried Chicken on Tuesday will begin testing an overhauled sandwich featuring a bigger chicken filet and other modifications that could reignite last year’s Great Chicken Sandwich Wars with rivals Popeyes and Chick-fil-A.

FILE PHOTO: A Kentucky Fried Chicken (KFC) logo is pictured in North Miami Beach, Florida, U.S. April 6, 2017. REUTERS/Carlo Allegri/File Photo

KFC, a unit of Yum! Brands Inc (YUM.N), will sell the new version of its chicken sandwich for 26 days – or until supplies run out – at 15 locations in and around Orlando, Florida for $3.99.

The larger

Read More

Demand rise, output cuts could mean oil market balance in June

spike

LONDON (Reuters) – Recovering demand as coronavirus lockdowns ease combined with output cuts by top producers could balance global oil markets as soon as June, some analysts and banks predict.

FILE PHOTO: The sun is seen behind a crude oil pump jack in the Permian Basin in Loving County, Texas, U.S., November 22, 2019. REUTERS/Angus Mordant/File Photo

“Bullish sentiment continues to gather momentum as we move closer to June, when … the global crude balance is set to reach net short territory, to the tune of a non-negligible 1.5 million barrels per day (bpd), its tightest point since August 2019,”

Read More

NYSE to reopen trading floor closed by coronavirus

spike

A nearly empty trading floor is seen as preparations are made for the return to trading at the New York Stock Exchange (NYSE) in New York, U.S., May 22, 2020. REUTERS/Brendan McDermid

NEW YORK (Reuters) – The New York Stock Exchange will partially reopen the trading floors at its iconic 11 Wall Street building on Tuesday for the first time since March 20 when the bourse was forced to go all-electronic due to the coronavirus pandemic.

The Intercontinental Exchange Inc’s (ICE.N) NYSE floor will be different, with protective masks, strict social distancing requirements, and just around a quarter

Read More

Sanofi shares down despite $13 billion Regeneron payday

spike

PARIS (Reuters) – Shares in Sanofi (SASY.PA) fell on Tuesday despite the French drugmaker’s impending $13 billion payday from selling most of its 20.6% stake in U.S. partner Regeneron (REGN.O).

FILE PHOTO: The logo of Sanofi is seen at the company’s headquarters in Paris, France, April 24, 2020. REUTERS/Charles Platiau/File Photo

By 1111 GMT, shares in Sanofi were down 1%, in line with the broader European health index .SXDP.

The stake sale, part of a major overhaul under new CEO Paul Hudson, will see Regeneron repurchase $5 billion of its stock with the rest set for

Read More